Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated

Artikelnummer: ABS-S1N-M13A1-100MG
Artikelname: Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated
Artikelnummer: ABS-S1N-M13A1-100MG
Hersteller Artikelnummer: S1N-M13A1-100mg
Alternativnummer: ABS-S1N-M13A1-100MG
Hersteller: AcroBiosystems
Wirt: Mouse
Kategorie: Antikörper
Spezies Reaktivität: Mouse
Konjugation: Unconjugated
AntiSARSCoV2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (S1NM13A1) is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immunized
Tag: Human IgG1 | Human Kappa
Puffer: PBS, pH7.4
Quelle: Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (S1N-M13A1) is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immuni
Expression System: HEK293
Reinheit: 95%
Formulierung: Liquid
Target-Kategorie: Spike RBD
Antibody Type: Recombinant Antibody
Anwendungsbeschreibung: This antibody is developed for detecting the SARS-CoV-2 Spike Protein in cell supernatant or SARS-CoV-2 virus in vitro by sandwich ELISA assay.
S1N-M13A1-100mg